Banner Ads

Initiate with ‘buy’ on Alkem Lab; target price Rs 3,315 https://ift.tt/eA8V8J

March 26, 2021 at 08:09AM
Alkem boasts best-in-class domestic anti-infectives portfolio and leadership in multiple GI and vitamin sub-therapies. Its Chronic base is small, but growing at 18-20%.

from The Financial Express

Post a Comment

0 Comments